Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Karyopharm Therapeutics, Inc
Scientific Title
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)